Web
DirectoryNeuroGeneration: Neural Stem Cell Therapies Biotechnology for Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS
NeuroGeneration is a biotherapeutics company that develops new treatments and products for patients with neurological diseases, including Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
March 1, 2010
US Patent issued to NeuroGeneration.The USPTO has issued a key patent for NeuroGeneration's ....read more: PRESS RELEASE
February 16, 2009
Grounbreaking paper publishes long term results of a successful Phase I Clinical Trial .. more>
October 15, 2008
NeuroGeneration named as one of 27 industry trendsetters for 2009 in Stem Cell Approaches in Neurology and Psychiatry Today ... more>
NeuroGeneration has been authorized by the FDA to conduct a phase II clinical trial for Parkinson's disease. This trial is currently on hold until we complete our cGMP processing center.
